Skip to main content
SpringerLink
Log in

Chemotherapy in advanced ovarian cancer

  • Original Papers
  • Clinical Oncology or Epidemiology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

The chemotherapy of advanced ovarian cancer is reviewed. Treatment with single agents results in low remission rates and few complete remissions. The results have been improved with modern combination chemotherapy, which includes cisplatin, although a longer follow up is needed for definite conclusions to be made concerning survival. Toxicity and drug resistance remain important problems. The future prospects of treatment with emphasis on intraperitoneal chemotherapy are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barker, GH, Wiltshaw E (1981) Randomized trial comparing low dose cisplatin and chlorambucil with advanced ovarian cancer. Lancet i:747–750

    Article  Google Scholar 

  • Barlow JJ, Blumenson LE (1979) Letter to the editor. New Eng J Med 22:676

    Google Scholar 

  • Bruckner HW, Cohen CJ, Goldberg JD, Kabakow B, Wallach RC, Deppe G, Greenspan EM, Gusberg SB, Holland JF (1981) Improved chemotherapy for ovarian cancer with cis-diaminedichloroplatinum and adriamycin. Cancer 47:2288–2294

    PubMed  Google Scholar 

  • Bush RS (1979) Letter to the editor. New Eng J Med 22:676

    Google Scholar 

  • Carmo Pereira J, Costa FO, Henriques E, Ricardo JA (1981) Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (HexaCAF). Cancer 48:1947–1951

    PubMed  Google Scholar 

  • Chassagne D (1980) Radiotherapy in the treatment of stages III and IV. In: van Oosterom AT, Muggia FM, Cleton FJ (eds) Therapeutic progress in ovarian cancer. Boerhaave Series, Leiden (pp 27–41)

  • Dunnick NR, Jones RB Doppman JL, Speyer J, Myers CE (1979) Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics. AJR 133:221–223

    PubMed  Google Scholar 

  • Edmonson JH, Fleming TR, Decker DG, Malkasian GD, Jorgenson EO, Jefferies JA, Webb MJ, Kvols LK (1979) Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual discase. Cancer Treat Rep 63:241–247

    PubMed  Google Scholar 

  • Gershenson DM, Wharton TJ, Herson J, Edwards CL, Rutledge FN (1981) Single agent cisplatin therapy for advanced ovarian cancer. Obstet Gynecol 58:487–496

    PubMed  Google Scholar 

  • Greene MH, Boice JD, Greer BE, Blessing JA, Dembo AJ (1982) Acute non lymphocytic leukemia after therapy with alkylating agents in ovarian cancer. New Eng J Med 307:1416–1421

    PubMed  Google Scholar 

  • Griffiths CT (1980) Cytoreductive surgical treatment in the management of advanced ovarian cancer. In: van Oosterom AT, Muggia FM, Cleton FJ (eds) Therapeutic progress in ovarian cancer. Boerhaave Series, Leiden (pp 3–13)

  • Griffiths CT, Parker LM, Fuller JJ (1979) Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 63:235–240

    PubMed  Google Scholar 

  • Hogan WM, Young RC (1982) Gynecologic malignancies. In: Pinedo HM (ed) Cancer chemotherapy, Exerpta Medica, Amsterdam (pp 309–338)

    Google Scholar 

  • Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL (1982) Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Int Med 97:845–851

    PubMed  Google Scholar 

  • Howell SB, Pfeifle CL, Wung WE, Olshen RA, (1983) Intraperitoneal cisplatin with systemic thiosulfate protection. Cancer Res 43:1426–1431

    PubMed  Google Scholar 

  • Hreschchynshyn M, Graham JB (1967) Chemotherapy of ovarian cancer. Int Surg 47:398–401

    PubMed  Google Scholar 

  • Jones RB, Myers CE, Guarino AM, Dedrick RL, Hubbard SM, De Vita VT (1978) High volume intraperitoneal chemotherapy (Belly Bath) for ovarian cancer. Cancer Chemother Pharmacol 1:161–166

    Article  PubMed  Google Scholar 

  • Katz ME, Schwartz PE, Kapp DS, Luikart S (1981) Epithelial carcinoma of the ovary: current strategies. Ann Int Med 95:98–111

    PubMed  Google Scholar 

  • Masterson JG, Nelson JH (1965) The role of chemotherapy in the treatment of gynecologic malignancy. Am J Obst Gynecol 93:1102–1111

    Google Scholar 

  • Neijt JP, ten Bokkel Huinink WW, Burg Mel vd, van Oosterom AT, Vriesendorp R, Boven E, Kooyman CD, v Houwelingen JC, Pinedo HM (1983) Proceedings of ASCO: ASCO abstracts, C 577

  • Neijt JP, van Lindert ACM, Vendrik CJP, Roozendaal KJ, Struyvenberg A, Pinedo HM (1979) HexaCAF combination chemotherapy and other multiple drug regimens in advanced ovarian carcinoma: present and future. Neth J Med 22:38–44

    PubMed  Google Scholar 

  • Neijt JP (1983) Combination chemotherapy in the treatment of advanced ovarian carcinoma. Dissertation. Utrecht, The Netherlands

  • Omura GA, Blessing JA, Morrow CB, Buchsbaum HJ, Homesley HD (1981) follow up on a randomized trial of melphalan vs melphalan plus hexamethylmelamine vs adriamycin plus cyclophosphamide in advanced ovarian adenocarcinoma. Proceedings of ASCO abstracts, C 537

  • Ozols RF, Young RC, Speyer JL, Sugarbaker PH, Greene R, Jenkins J, Myers CE (1982) Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 42:4265–4269

    PubMed  Google Scholar 

  • Park RC, Blom J, Disaia PJ, Lagasse LD, Blessing JA (1980) Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5 fluoro-uracil and dactinomycin or with the combination of cytoxan, 5 fluoro-uracil and dactinomycin. Cancer 45:2529–2542

    PubMed  Google Scholar 

  • Pretorius RG, Hacker NF, Berek JS, Ford LC, Chamorro T, Lagase LD (1982) Intraperitoneal cis-platinum in patients with ovarian carcinoma. ASCO Abstracts, C437

  • Reimer RR, Hoover R, Fraumeni JF, Young RC (1977) Acute leukemia after alkylating agent therapy of ovarian cancer. New Eng J Med 297:177–181

    PubMed  Google Scholar 

  • Rutledge FN, Fletcher GH, Smith JP, Wharto JT, Delglos L, Day TG, Gallager HS (1976) Gynecologic cancer. In: Clark LE, Clifton DH (eds) Year Book Med Publishers (pp 263–308)

  • Schwartz PE (1981) Surgical management of ovarian cancer. Arch Surg 116:99–106

    PubMed  Google Scholar 

  • Scott JS, Anderson JA, Barr W, Bleeken NM, Calman KC, Guthrie D, Hudson CN, Laing AM, Langley FA, MacDonald H, Peto J, Rocker I, Tattersall MHN, Whitehouse JMA (1981) Medical research council study on chemotherapy in advanced ovarian cancer. Br J Obst Gynecol 88:1174–1185

    Google Scholar 

  • Smith JP (1978) Chemotherapy of gynecologic cancer. Surg Clin North Am 58:201–215

    PubMed  Google Scholar 

  • Smith JP, Day TG (1979) Review of ovarian cancer at the university of Texas Systems Cancer center, MD Anderson Hospital and Tumor Institute. Am J Obst Gynecol 135:984–990

    Google Scholar 

  • Speyer JL, Collins JM, Dedrick RL, Brennan MF, Buckpitt AR, Londer H, DeVita VT, Myers CE (1980) Phase I and pharmacological studies of 5 fluoro-uracil administered intraperitoneally. Cancer Res 40:567–572

    PubMed  Google Scholar 

  • Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW, Myers CE (1981) Portal levels and hepatic clearance of 5-fluorouracil after i.p. administration in humans. Cancer Res 41:1916–1922

    PubMed  Google Scholar 

  • Sturgeon JFG, Fine S, Gospodarowicz MK, Dembo AJ, Bean HA, Bush RS, Beale FA, Pringle JF, Thomas SM, Herman JG (1982) A randomized trial of melphalan alone versus combination chemotherapy in advanced ovarian cancer. Proceedings of ASCO. ASCO Abstracts C418

  • Tobias JS, Griffiths CT (1976) Management of ovarian carcinoma. New Eng J Med 294:877–882

    PubMed  Google Scholar 

  • Tropé C (1981) A prospective and randomized trial comparison of melphalan vs adriamycin, melphalan in advanced ovarian carcinoma. Proc Am Ass Clin Oncol 22:469

    Google Scholar 

  • Turbow MM, Jones H, Yu VK, Greenberg B, Hannigan J, Torti FM (1980) Chemotherapy of ovarian carcinoma: a comparison of melphalan versus adriamycin-cyclophosphamide. Proceedings of AACR and ASCO. AACR Abstract, C 785

  • Vogl S, Pagano M, Kaplan B (1982) Diamminedichloroplatinum (D) based combination chemotherapy (CT) is superior to melphalan (M) for advanced ovarian cancer when age is ≧50 and tumor diameter >2 cm. ASCO Abstract, C462

  • Wallach RC, Kabakow B, Blinick G, Antopol W (1970) Thiotepa chemotherapy for ovarian carcinoma. Obstet Gynecol 35:278–286

    PubMed  Google Scholar 

  • Wharton JT, Rutledge F, Smith JP, Herson J, Hodge MP (1979) Hexamethylmelamine: an evaluation of its role in the treatment of ovarian cancer. Am J Obstet Gynecol 133:833–844

    PubMed  Google Scholar 

  • Wiltshaw E, Evans BD, Jones AC, Baker JW, Calvert AH (1983) Letter to the Editor: JM8, successor to cisplatin in advanced ovarian carcinoma? Lancet i:587

    Article  Google Scholar 

  • Young RC, Hubbard SP, DeVita VT (1974) The chemotherapy of ovarian carcinoma. Cancer Treat Rev 1:99–110

    Google Scholar 

  • Young RC, Chabner BA, Hubbard SP, Fisher RI, Bender RA, Anderson T, Simon RM, Canellos GP, DeVita VT (1978) Advanced ovarian carcinoma: a prospective clinical trial of melfalan versus combination chemotherapy. New Eng J Med 299:1261–1266

    PubMed  Google Scholar 

  • Young RC, Knapp RC, Perez CA (1982) Cancer of the ovary. In: DeVita VT, Hellmann S, Rosenberg SA (eds) Cancer. Philadelphia: Lippincott (pp 884–914)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, University Hospital, NL-2333 AA, Leiden, The Netherlands

    C. J. Rodenburg & F. J. Cleton

Authors
  1. C. J. Rodenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. J. Cleton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodenburg, C.J., Cleton, F.J. Chemotherapy in advanced ovarian cancer. J Cancer Res Clin Oncol 107, 99–105 (1984). https://doi.org/10.1007/BF00399380

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00399380

Key words

Search

Navigation